T-cell immunity generated by recombinant adenovirus vaccines (Q36837129)

16 August 2017

1 reference

title

T-cell immunity generated by recombinant adenovirus vaccines (English)

1 reference

16 August 2017

1 reference

Jonathan L Bramson

6

0 references

author name string

Teng Chih Yang

1

1 reference

16 August 2017

James B Millar

2

1 reference

16 August 2017

Natalie Grinshtein

3

1 reference

16 August 2017

Jennifer Bassett

4

1 reference

16 August 2017

Jonathan Finn

5

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Expert Review of Vaccines

16 August 2017

published in

1 reference

16 August 2017

volume

6

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

347-356

1 reference

Can successful vaccines teach us how to induce efficient protective immune responses?

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Influenza and the challenge for immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Duration of antiviral immunity after smallpox vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Adenovirus vector-based vaccines for human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Viral vectors for malaria vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Adenovirus as vehicle for anticancer genetic immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Effector and memory T-cell differentiation: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Cytotoxic T Lymphocyte Responses to Proteins Encoded by Heterologous Transgenes TransferredIn Vivoby Adenoviral Vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Adenoviruses as vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

On the role of CD4 T cells in the CD8 T-cell response elicited by recombinant adenovirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Detailed analysis of the CD8 T-cell response following adenovirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

T cell immunity in lymphoid and non-lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8 memory T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

CD4( ) T cell effectors can become memory cells with high efficiency and without further division

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Progressive differentiation and selection of the fittest in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Unidirectional development of CD8 central memory T cells into protective Listeria-specific effector memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Initial T cell frequency dictates memory CD8 T cell lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Dendritic cells maximize the memory CD8 T cell response to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Central memory self/tumor-reactive CD8 T cells confer superior antitumor immunity compared with effector memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Feedback regulation of pathogen-specific T cell priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Late priming and variability of epitope-specific CD8 T cell responses during a persistent virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Memory CD8 T-cell differentiation during viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Establishment and recall of CD8 T-cell memory in a model of localized transient infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Inflaming the CD8 T cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

The innate immune response to adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Persistent antigen presentation after acute vesicular stomatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Helping the CD8( ) T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Cognate CD4( ) T cell licensing of dendritic cells in CD8( ) T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

CD4 T cells are required for secondary expansion and memory in CD8 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Developing and maintaining protective CD8 memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Epidermal viral immunity induced by CD8alpha dendritic cells but not by Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Bone marrow-derived cells expand memory CD8 T cells in response to viral infections of the lung and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Langerhans cells renew in the skin throughout life under steady-state conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Development of nonhuman adenoviruses as vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Neutralizing antibodies and CD8 T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Neutralized adenovirus-immune complexes can mediate effective gene transfer via an Fc receptor-dependent infection pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Human adenovirus type 35: nucleotide sequence and vector development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Development and assessment of human adenovirus type 11 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Development and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Development of an Ad7 cosmid system and generation of an Ad7deltaE1deltaE3HIV(MN) env/rev recombinant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Chimpanzee-origin adenovirus vectors as vaccine carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Adenovirus type 37 uses sialic acid as a cellular receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Activation of human CD4 cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

Recombinant Adenovirus Vaccines Can Successfully Elicit CD8 T Cell Immunity under Conditions of Extreme Leukopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586/14760584.6.3.347

21 January 2018

Identifiers

DOI

10.1586/14760584.6.3.347

1 reference

16 August 2017

1 reference